ARTICLE | Company News
Rigel Inc., Pfizer deal
January 29, 2001 8:00 AM UTC
The companies extended for an additional year their 1999 deal to use RIGL's peptide libraries to identify intracellular targets that prevent B cells from producing immunoglobulin E (IgE), to treat all...